← back to search

Derek T. Armstrong

Johns Hopkins University · US
Area of research
Infectious Diseases · Epidemiology
Research interest
Research interests include Tuberculosis Research and Epidemiology, Mycobacterium research and diagnosis, Infectious Diseases and Tuberculosis, and Diagnosis and treatment of tuberculosis.
h-index
20
citations
3,083
works
52
NIH funding
—
primary concept
—
email
✉ Find email ↗

Recent publications

Direct detection of SARS-CoV-2 RNA using high-contrast pH-sensitive dyes
Journal of Biomolecular Techniques JBT 2021cited by 27position: middledoi
Repeated Coronavirus Disease 2019 Molecular Testing: Correlation of Severe Acute Respiratory Syndrome Coronavirus 2 Culture With Molecular Assays and Cycle Thresholds
Clinical Infectious Diseases 2020cited by 175position: middledoi
Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study
The Lancet Infectious Diseases 2017cited by 685position: middledoi
Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance
Nature Genetics 2017cited by 296position: middledoi
Evaluation of a Rapid Molecular Drug-Susceptibility Test for Tuberculosis
New England Journal of Medicine 2017cited by 145position: middledoi
Point-of-care C-reactive protein-based tuberculosis screening for people living with HIV: a diagnostic accuracy study
The Lancet Infectious Diseases 2017cited by 141position: middledoi
Predictors and outcomes of mycobacteremia among HIV-infected smear- negative presumptive tuberculosis patients in Uganda
BMC Infectious Diseases 2015cited by 86position: middledoi
Diagnostic Accuracy of a Rapid Urine Lipoarabinomannan Test for Tuberculosis in HIV-Infected Adults
JAIDS Journal of Acquired Immune Deficiency Syndromes 2014cited by 84position: middledoi
Comparative performance of urinary lipoarabinomannan assays and Xpert MTB/RIF in HIV-infected individuals
AIDS 2014cited by 54position: middledoi
Sensititre MYCOTB MIC Plate for Testing Mycobacterium tuberculosis Susceptibility to First- and Second-Line Drugs
Antimicrobial Agents and Chemotherapy 2013cited by 107position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Moses Joloba · UCLouvain4 papers (2013–2015)Jerrold J. Ellner · South African Tuberculosis Vaccine Initiative4 papers (2013–2015)Susan E. Dorman · Medical University of South Carolina4 papers (2013–2015)— · 3 papers (2013–2015)Yukari C. Manabe · Harvard University3 papers (2014–2015)Molly Holshouser · Johns Hopkins Medicine3 papers (2014–2015)— · 3 papers (2014–2015)Maunank Shah · Baltimore City Health Department3 papers (2014–2015)David Alland · Rutgers, The State University of New Jersey2 papers (2013–2014)Heba H. Mostafa · University of Rochester Medical Center2 papers (2020–2021)Bareng A. S. Nonyane · Johns Hopkins University1 papers (2014–2014)Vineshree Mischka Moodley · University of Cape Town1 papers (2014–2014)Damalie Nakanjako · Indiana University – Purdue University Indianapolis1 papers (2015–2015)C. Paul Morris · Australian National University1 papers (2020–2020)Karen C. Carroll · Johns Hopkins University1 papers (2020–2020)Luke D. Lavis · Howard Hughes Medical Institute1 papers (2021–2021)Brendan D. Smith · Massachusetts Institute of Technology1 papers (2020–2020)Harriet Mayanja‐Kizza · Case Western Reserve University1 papers (2015–2015)Wyatt Korff · Columbia University1 papers (2021–2021)Jonathan B. Grimm · Howard Hughes Medical Institute1 papers (2021–2021)